RESTATEMENT (Table)

3 Months Ended

Mar. 31, 2017

Accounting Changes and Error Corrections [Abstract]

Schedule of balance sheet

The following table represents the balance sheet as previously reported, restatement adjustment, and as restated as of March 31, 2017:

				Restatement
	As Previously Filed			Adjustment			As Restated
	(Unaudited)						(Unaudited)
ASSETS
Current Assets:
Cash	$	100,135					$	100,135
Accounts receivable		16,419						16,419
Other receivables		23,276						23,276
Vendor notes receivable, net of allowance for doubtful		-						-
collection of $360,993		-						-
Vendor advances receivable		-						-
Inventories, at lower cost or market, principally average cost method		1,493,872						1,493,872
Prepaid expense		170,834						170,834
Total Current Assets		1,804,536			-			1,804,536
Equipment, net of accumulated depreciation of $13,500		218,739			346,843			565,582
Other Assets:		-						-
Licensing agreement, net of $6,250 of accumulated amortization in 2017		118,750						118,750
Goodwill		1,770,221			(1,770,221	)		-
TOTAL ASSETS	$	3,912,246		$	(1,423,378	)	$	2,488,868
LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIT)
Current Liabilities:
Accounts payable	$	331,790					$	331,790
Accounts payable - related parties		66,383						66,383
Accrued liabilities		86,785						86,785
Convertible note payable, net of debt discount of $356,250 in 2016		1,875,000						1,875,000
Note payable - related party		598,000						598,000
Insurance premium note payable		101,433						101,433
Total Current Liabilities		3,059,391			-			3,059,391
Stockholders' Equity (Deficit):
Common Stock, $0.001 par value, 100,000,000 shares authorized
17,976,175 and 15,754,000 shares issued and outstanding at
March 31, 2017 and  December 31, 2016, respectively		17,976						17,976
Additional paid-in capital		2,087,333						2,087,333
Stock subscription receivable		-						-
Accumulated (Deficit)		(1,252,454	)		(1,423,378	)		(2,675,832	)
Total Stockholders' Equity (Deficit)		852,855			(1,423,378	)		(570,523	)
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIT)	$	3,912,246		$	(1,423,378	)	$	2,488,868

Schedule of operations

The following table represents the income statement as previously reported, restatement adjustment, and as restated as of March 31, 2017:

				Restatement
	As Previously Filed			Adjustment			As Restated
Gross Sales	$	653,784					$	653,784
Customer incentives, discounts, returns, and allowances		-						-
Net sales		653,784			-			653,784
Cost of Goods Sold, includes depreciation and amortization of $18,920
for the three months ended March 31, 2017		466,433			8,457			474,890
Gross Margin		187,351			(8,457	)		178,894
Operating Expenses
Selling and marketing		116,833						116,833
Corporate general and administrative		578,402						578,402
Employee salaries and related expenses		167,987						167,987
Depreciation expense		379						379
Total operating expenses		863,601			-			863,601
Loss from Operations		(676,250	)		(8,457	)		(684,707	)
Other Income (Expenses)
Loss on vendor notes receivable collectibility		-			1,414,921			1,414,921
Interest expense		421,180						421,180
Profit (Loss) before Income Taxes		(1,097,430	)		(1,423,378	)		(2,520,808	)
Provision for Income Taxes
Net Profit (Loss)	$	(1,097,430	)	$	(1,423,378	)	$	(2,520,808	)
Loss per share
Basic and fully diluted:
Weighted average number of shares outstanding		17,118,431			17,118,431			17,118,431
Loss per share	$	(0.06	)	$	(0.09	)	$	(0.15	)

Schedule of stockholders equity

The following table represents the statement of stockholder’s equity (deficit) as previously reported, and as restated as of March 31, 2017:

	Common Shares				Additional Paid-In			Preferred		Subscription			Accumulated
	Number		Par Value		Capital			Shares		Receivable			(Deficit)			Total
Balance as of January 1, 2017		15,754,000	$	15,754	$	799,180				$	(167,500	)	$	(155,024	)	$	492,410
Reverse merger and recapitalization		601,375		601		(601	)										0
Subscriptions collected											167,500						167,500
Common stock issued for founder shares		625,000		625		-											625
Common stock issued for cash @ $1.25 per share		946,200		946		1,181,804											1,182,750
Organizational and fund raising costs		-		-		(17,000	)										(17,000	)
Common stock issued for payment of legal fees @ $2.50 per share		49,600		50		123,950											124,000
Net loss for period ended March 31, 2017 (Restated)		-		-		-		-			-			(2,520,808	)		(2,520,808	)
Balance as of March 31, 2017 (Restated)		17,976,175	$	17,976	$	2,087,333		$	-	$	-		$	(2,675,832	)	$	(570,523	)

Schedule of cash flows

The following table represents the statement of cash flow as previously reported, restatement adjustment, and as restated as of March 31, 2017:

				Restatement
	As Previously Filed			Adjustment			As Restated
Cash flows from operating activities:
Net (Loss)	$	(1,097,430	)	$	(1,423,378	)	$		(2,520,808	)
Adjustments to reconcile Net (Loss) to Net Cash provided by operations:
Debt discount amortization		356,250			-				356,250
Depreciation and amortization		11,343			8,457				19,800
Common stock issued for legal fees		124,000			-				124,000
Uncollectible vendor notes receivable		-			1,414,921				1,414,921
Changes in Current Assets and Liabilities
Vendor advances receivable		186,486			-				186,486
Accounts receivable		4,546			-				4,546
Other receivables		(2,465	)		-				(2,465	)
Inventories		(765,320	)		-				(765,320	)
Prepaid expenses		9,927			-				9,927
Accounts payable		252,984			-				252,984
Accounts payable		66,383			-				66,383
Accrued liabilities		86,785			-				86,785
Net cash used in operating activities		(766,511	)						(766,511	)
Cash flows from investing activities
Purchase of equipment		(36,017	)		-				(36,017	)
Net cash used in investing activities		(36,017	)		-				(36,017	)
Cash flow from financing activities
Note payment - related party		(362,000	)		-				(362,000	)
Insurance premium note payments		(79,328	)		-				(79,328	)
Sale of common stock		1,350,875			-				1,350,875
Organization and fundraising costs		(17,000	)		-				(17,000	)
Net cash provided by financing activities		892,547			-				892,547
Net increase in cash		90,019			-				90,019
Cash, beginning of period		10,116			-				10,116
Cash, end of period	$	100,135		$	-		$		100,135
Supplemental cash flow disclosures
Cash paid during the period for -
Interest	$	1,297		$	-			$	1,297
Income taxes	$	-		$	-			$	-

Non-cash investing and financing activities:
Vendor note receivable foreclosure -
Vendor notes receivable	$	2,585,000		$	(1,414,921	)	$	1,170,079
Vendor advances receivable		(96,552	)					(96,552	)
Accounts receivable		(20,965	)					(20,965	)
Inventories		(509,447	)					(509,447	)
Equipment		(187,815	)		(355,300	)		(543,115	)
Goodwill		(1,770,221	)		1,770,221			-
Other receivables		(20,811	)					(20,811	)
Accounts payable		20,811						20,811
Insurance premium note payable		180,761						180,761
Prepaid expenses		(180,761	)					(180,761	)
Common stock		601						601
Additional paid-in-capital		(601	)					(601	)
	$	-		$	-		$	-